NanoGroup S.A. is launching the next phase of research with a proprietary innovative organ perfusion fluid
After announcing positive results from preliminary studies comparing kidneys perfused with NanOX 10 and NanOX 20 fluids with the current standard used in transplantation, NanoGroup